[News Today] US coupang investors' petition against Korea

KBS 2026. 1. 23. 16:50
음성재생 설정 이동 통신망에서 음성 재생 시 데이터 요금이 발생할 수 있습니다. 글자 수 10,000자 초과 시 일부만 음성으로 제공합니다.
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

[LEAD]
Two major U.S. investment firms, also shareholders of Coupang have moved to file an investor-state dispute settlement arbitration against the South Korean government. They claim the government and the National Assembly unfairly targeted Coupang following its personal data leak, causing significant financial losses.

[REPORT]
The Korean justice ministry said Thursday that Coupang's two investors, Greenoaks and Altimeter, filed Investor-State Dispute Settlement arbitration against the Korean government under the Korea-U.S. Free Trade Agreement.

In the notice of intent, the investors argued that Korea's National Assembly and its administration targeted Coupang by investigating the company and issuing various administrative measures as well as making threatening remarks following Coupang's personal data leak that occurred on December 1st, 2025.

Then, the U.S. investors described the move as an egregious violation of the Treaty and that the government's actions have erased billions of dollars of U.S. investment in Coupang.

An arbitration claim is a letter notifying of the claimant's intent to launch arbitration and official arbitration can begin 90 days after the claim was filed.

The Ministry of Justice said that the investor-state dispute settlement response team will work together with other pertinent agencies to closely review the legal issues.

The Korean government also explained that it would respond actively to the matter by disclosing related information to ensure people's right to know and enhance procedural transparency.

■ 제보하기
▷ 전화 : 02-781-1234, 4444
▷ 이메일 : kbs1234@kbs.co.kr
▷ 카카오톡 : 'KBS제보' 검색, 채널 추가
▷ 카카오 '마이뷰', 유튜브에서 KBS뉴스를 구독해주세요!

KBS

Copyright © KBS. All rights reserved. 무단 전재, 재배포 및 이용(AI 학습 포함) 금지